Literature DB >> 31932983

Development and Characterization of PCL Electrospun Membrane-Coated Bletilla striata Polysaccharide-Based Gastroretentive Drug Delivery System.

Zhouying Li1, Rui Zeng2, Ling Yang1, Xiaodong Ren3, Katherine G Maffucci4, Yan Qu5.   

Abstract

The purpose of this study was to investigate the potential of Bletilla striata polysaccharide (BSP, a natural glucomannan material) for the development of a gastroretentive drug delivery system for the first time. Novel BSP-based porous wafer was prepared for levofloxacin hydrochloride (LFH) delivery by combining floating, swelling, and mucoadhesion mechanisms. The influences of BSP and ethyl cellulose (EC) on drug release and mucoadhesive strength were studied by 32 factorial design. The optimized matrix was coated with polycaprolactone (PCL) electrospun membrane by electrospinning and heat treatment technology. The optimized formula (F6, coated) exhibited Q4 h of 41.20 ± 1.90%, Q8 h of 76.49 ± 1.69%, and mucoadhesive strength of 86.11 ± 1.33 gf, and its drug release profile most closely resembled the Korsmeyer-Peppas model with anomalous diffusion driving mechanism. F6 (coated) also presented excellent buoyancy, preferred swelling characteristic due to the porous structure formed by freeze-drying. Meanwhile, the internal morphology, physical state, drug-excipient compatibility, and thermal behavior were recorded. The negligible cytotoxicity of F6 (coated) was observed in human gastric epithelial cell cultures. In the in vitro antimicrobial experiment, the prepared wafer exhibited obvious bacterial inhibition zone, and due to its longer gastric retention, the wafer also performed a more effective Helicobacter pylori clearance than free LFH in vivo. Graphical abstract.

Entities:  

Keywords:  Bletilla striata polysaccharide; Helicobacter pylori; controlled release; floating; gastroretentive

Mesh:

Substances:

Year:  2020        PMID: 31932983     DOI: 10.1208/s12249-019-1607-5

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  2 in total

1.  Application of the pH-Responsive PCL/PEG-Nar Nanofiber Membrane in the Treatment of Osteoarthritis.

Authors:  Zetao Wang; Yanping Zhong; Si He; Ruiming Liang; Chuanan Liao; Li Zheng; Jinmin Zhao
Journal:  Front Bioeng Biotechnol       Date:  2022-04-27

Review 2.  Advancement of Nanofibrous Mats and Common Useful Drug Delivery Applications.

Authors:  Hamza Abu Owida; Jamal I Al-Nabulsi; Feras Alnaimat; Ashraf Al Sharah; Muhammad Al-Ayyad; Nidal M Turab; Mustafa Abdullah
Journal:  Adv Pharmacol Pharm Sci       Date:  2022-04-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.